Yondelis , for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment .

Verified by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., November 19 , 2009 .
...